Acadian Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,455
| Closed | -$121K | – | 1702 |
|
|
2021
Q2 | $121K | Buy |
+3,455
| New | +$121K | ﹤0.01% | 1587 |
|
|
2020
Q4 | – | Sell |
-7,171
| Closed | -$202K | – | 2192 |
|
|
2020
Q3 | $202K | Sell |
7,171
-50,791
| -88% | -$1.43M | ﹤0.01% | 1444 |
|
|
2020
Q2 | $1.88M | Buy |
57,962
+13,118
| +29% | +$425K | 0.01% | 758 |
|
|
2020
Q1 | $1.83M | Buy |
44,844
+16,984
| +61% | +$692K | 0.01% | 630 |
|
|
2019
Q4 | $1.72M | Buy |
27,860
+22,954
| +468% | +$1.41M | 0.01% | 736 |
|
|
2019
Q3 | $357K | Buy |
4,906
+604
| +14% | +$44K | ﹤0.01% | 1173 |
|
|
2019
Q2 | $355K | Sell |
4,302
-3,874
| -47% | -$320K | ﹤0.01% | 1092 |
|
|
2019
Q1 | $578K | Buy |
8,176
+3,054
| +60% | +$216K | ﹤0.01% | 1062 |
|
|
2018
Q4 | $231K | Sell |
5,122
-1,265
| -20% | -$57.1K | ﹤0.01% | 1078 |
|
|
2018
Q3 | $361K | Buy |
+6,387
| New | +$361K | ﹤0.01% | 955 |
|
|
2015
Q4 | – | Sell |
-79,611
| Closed | -$3.15M | – | 1393 |
|
|
2015
Q3 | $3.15M | Buy |
+79,611
| New | +$3.15M | 0.02% | 471 |
|
|
2015
Q2 | – | Sell |
-1,474
| Closed | -$92K | – | 1353 |
|
|
2015
Q1 | $92K | Buy |
1,474
+714
| +94% | +$44.6K | ﹤0.01% | 1032 |
|
|
2014
Q4 | $43K | Buy |
+760
| New | +$43K | ﹤0.01% | 1051 |
|